MedPath

Shenzhen Raysight Intelligent Medical Technology Co., Ltd

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study

Completed
Conditions
Coronary Artery Disease
Heart Diseases
Coronary Stenosis
Vascular Diseases
Ischemia
Arteriosclerosis
Cardiovascular Diseases
Interventions
Other: AngioQFA
First Posted Date
2023-09-15
Last Posted Date
2025-05-16
Lead Sponsor
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Target Recruit Count
330
Registration Number
NCT06039748
Locations
🇨🇳

Jieyang People's Hospital, Jieyang, Guangdong, China

🇨🇳

The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China

🇨🇳

Renmin Hospital of Wuhan University, Wuhan, Hubei, China

and more 2 locations

Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)

Not Applicable
Not yet recruiting
Conditions
Arteriosclerosis
Coronary Artery Disease
Cardiovascular Diseases
Myocardial Ischemia
Vascular Disease Occlusive
Coronary Disease
Interventions
Procedure: VRS100 robotic-assisted PCI
Procedure: Manual PCI
First Posted Date
2023-09-13
Last Posted Date
2023-09-13
Lead Sponsor
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Target Recruit Count
204
Registration Number
NCT06032572
Locations
🇨🇳

West China Hospital of Sichuan University, Chengdu, Sichuang, China

🇨🇳

Shenzhen People's Hospital, Shenzhen, Guangdong, China

🇨🇳

Zhongshan Hospital, Shanghai, Shanghai, China

Evaluation of Health Economics for Noninvasive Coronary Fractional Flow Reserve Measurement Technology

Recruiting
Conditions
Coronary Artery Disease
Interventions
Diagnostic Test: CT-FFR
Diagnostic Test: Routine care
First Posted Date
2022-10-25
Last Posted Date
2022-10-25
Lead Sponsor
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Target Recruit Count
600
Registration Number
NCT05593120
Locations
🇨🇳

Wuhan Asia Heart Hospital, Wuhan, Hubei, China

Evaluation on the Effectiveness and Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery Stenosis

Conditions
Coronary Artery Disease
CT Angiography
Artificial Intelligence
Coronary Artery Stenosis
Interventions
Device: RuiXin-CoronaryAI software
First Posted Date
2022-04-11
Last Posted Date
2022-09-21
Lead Sponsor
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Target Recruit Count
615
Registration Number
NCT05320185
Locations
🇨🇳

Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China

🇨🇳

Tongji Hospital, Wuhan, Hubei, China

🇨🇳

Beijing Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath